Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QSRs Proposed As Alternatives To "Type Testing" In China and Korea

This article was originally published in The Gray Sheet

Executive Summary

Chinese officials responsible for medical device regulation in China's State Drug Administration might participate in a proposed quality system regulation training program tentatively slated for late summer.

You may also be interested in...



Device Type Testing, AE Reporting Systems To Be Clarified At Beijing Meeting

China's progress in adopting a quality system approach to medical device regulation in lieu of type testing requirements will be gauged by U.S. manufacturers during a U.S.-China Joint Commission on Commerce & Trade meeting in Beijing Nov. 12-13

Device Type Testing, AE Reporting Systems To Be Clarified At Beijing Meeting

China's progress in adopting a quality system approach to medical device regulation in lieu of type testing requirements will be gauged by U.S. manufacturers during a U.S.-China Joint Commission on Commerce & Trade meeting in Beijing Nov. 12-13

Commerce Eyes China’s MoH To Revive Stalled Reforms Six Months Post-WTO

The U.S. Deparment of Commerce (DoC) is charging an upcoming delegation to China with the task of determining why regulatory reforms in the country appear to have derailed in the past month

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014906

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel